Loading...

COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

New

Drug Delivery Devices Market by Device Type (Smart Pills, Inhalers & Nebulizers, Drug Eluting Stents, Safety Syringes, Implantable Drug Delivery Device, and Transdermal Patches, and, Others), End User (Hospitals and Diagnostic Centers, Ambulatory Surgery Centers and Clinics and Others), Global Opportunity Analysis and Industry Forecast, 2019–2026

A06095
Pages: 201
Mar 2020 | 968 Views
 
Author(s) : Sanjivan Gill , onkar sumant
Tables: 93
Charts: 47
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Drug Delivery Devices Market

Request Now !

Drug Delivery Devices Market Overview:

The global drug delivery devices market size accounted for $19,061 million in 2018, and is expected to reach $26,742 million by 2026, registering a CAGR of 4.3% from 2019 to 2026. 

Drug delivery devices are defined as medical devices that exclusively deliver a drug to the body through a specific route of administration. Furthermore, administration of a drug to the specific site leads to more accurate, easier, and less frequent dosing. In addition, the other benefits offered by drug delivery devices include lesser variability in systemic drug concentrations, which leads to absorption that is more reliable with the site and mechanism of action. Moreover, there are different types of drug delivery devices that are available in the market. For instance, some of the drug delivery devices include smart pills, inhalers, drug eluting stents, safety syringes, and, others. In addition, these devices are sued in different medical settings such as hospitals and diagnostic centers, ambulatory surgery centers and others.  

Drug Delivery Devices Market	 

Get more information on this report : Request Sample Pages

The major factor that contributes to the growth of the drug delivery devices market is rise in prevalence of chronic diseases across the globe. Furthermore, other factors that boost the drug delivery devices market growth include surge in geriatric population across the globe and rise in adoption of biologics worldwide. However, stringent government regulations associated with launch of new drug delivery devices hamper the growth of drug delivery devices market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.

Drug Delivery Devices Market Segmentation  

The drug delivery devices market size is studied on the basis of device type, route of administration, and region to provide a detailed assessment of the market. On the basis of device type, it is segmented into smart pills, inhalers, drug eluting stents, safety syringes, implantable drug delivery device, transdermal patches, and others. By route of administration, it is classified into hospitals & diagnostic centers, ambulatory surgical centers & clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

Drug Delivery Devices Market
By Device

Your browser does not support the canvas element.

Smart pills is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Segment Review

By product, inhalers & nebulizers acquired a major share of the drug delivery market in 2018 and is expected to continue this trend during the forecast period owing to factors such as surge in prevalence of respiratory diseases such as asthma across the globe. Furthermore, other factors such as the rise in awareness related to the use of inhalers and nebulizers in treatment of respiratory diseases is another factor that boost the growth of the drug delivery devices market. In addition, the smart pills segment is expected to exhibit the fastest CAGR owing to benefits associated with the use of these devices. For instance, smart pills have enabled monitoring of the results from different drug administrations, which heavily assist in various stages of drug development such as drug candidate profiling, drug candidate selection, and accelerating the development of new drugs. Further, this emerging technology presents significant opportunity for the medical industry to exploit modern digital innovations and take a lead position in the future of healthcare.

Drug Delivery Devices Market
By End user

Your browser does not support the canvas element.

Hospitals and Diagnostic Centers holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

By route of end user, hospitals and diagnostic centers acquired a major share of the drug delivery devices market in 2018, owing to surge in prevalence of chronic disorders that require treatment and include the use of drug delivery devices. In addition, ambulatory surgical centers are expected to exhibit the fastest CAGR during the forecast period owing to surge in number of ambulatory surgical centers across the globe. 

Drug Delivery Devices Market
By Geography

2026
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 5.1% during 2019-2026.

Get more information on this report : Request Sample Pages

By region, North America accounted for the major drug delivery devices market share in 2018 and is expected to continue this trend, owing to easy availability of drug delivery devices. Moreover, surge in the incidence of chronic diseases such as diabetes, cancer is another major reason that contributes to the growth of this market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period attributed to the increase in awareness regarding the use of drug delivery devices. Moreover, the constantly evolving life science industry drives the growth of the market in developing economies such as India, China, and South Korea. 

The global drug delivery devices market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include 3M Company, AstraZeneca PLC, Becton, Dickinson and Company, Boehringer Ingelheim group, Consort Medical plc, GlaxoSmithKline plc, Insulet Corporation, Medtronic Plc, Sulzer Ltd. (Medmix Systems AG), and West Pharmaceuticals Services, Inc.

Key Benefits for Stakeholders:

  • This report entails a detailed quantitative analysis along with the current global drug delivery devices market trends from 2018 to 2026 to identify the prevailing opportunities along with the strategic assessment.
  • The drug delivery devices market forecast is studied from 2019 to 2026. 
  • The market size and estimations are based on a comprehensive analysis of key developments in the drug delivery devices industry. 
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the drug delivery devices market

Key Market Segments:

By Device Type

  • Smart pills
  • Inhalers
  • Drug eluting stents 
  • Safety syringes 
  • Implantable drug delivery device
  • Transdermal patches
  • Others

By End User

  • Hospitals & Diagnostic Centers 
  • Ambulatory Surgical Centers & Clinics 
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany 
    • France 
    • UK 
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan 
    • China 
    • India 
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Saudi Arabia 
    • South Africa
    • Rest of LAMEA                                   
 

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Top player positioning

3.2.1. Top investment pockets

3.3. Porter's five force analysis
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rising prevalence of chronic diseases
3.4.1.2. Growth in the biologics market
3.4.1.3. Rapid rise in the aging population

3.4.2. Restraints

3.4.2.1. Risk of needlestick injuries
3.4.2.2. Stringent government regulations

3.4.3. Opportunity

3.4.3.1. High growth prospects in the emerging markets

3.4.4. Impact Analyses

CHAPTER 4: DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Smart pills

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Inhalers and Nebulizers

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Drug Eluting Stents

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

4.5. Safety Syringes

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

4.6. Transdermal Patches

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country

4.7. Others

4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country

CHAPTER 5: GLOBAL DRUG DELIVERY DEVICES MARKET, BY END USER

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals and Diagnostic Centers

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Ambulatory Surgery Centers and Clinics

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Others

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

CHAPTER 6: DRUG DELIVERY DEVICES CAMERA MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities
6.2.2. North America Drug delivery devices market, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. Drug delivery devices market, by device type
6.2.2.1.2. U.S. Drug delivery devices market, by end user

6.2.2.2. Canada

6.2.2.2.1. Canada Drug delivery devices market, by device type
6.2.2.2.2. Canada Drug delivery devices market, by end user

6.2.2.3. Mexico

6.2.2.3.1. Mexico Drug delivery devices market, by device type
6.2.2.3.2. Mexico Drug delivery devices market, by end user

6.2.3. North America Drug delivery devices market, by device type
6.2.4. North America Drug delivery devices market, by end user

6.3. Europe

6.3.1. Key market trends and opportunities
6.3.2. Europe Drug delivery devices market, by country

6.3.2.1. Germany

6.3.2.1.1. Germany Drug delivery devices market, by device type
6.3.2.1.2. Germany Drug delivery devices market, by end user

6.3.2.2. France

6.3.2.2.1. France Drug delivery devices market, by device type
6.3.2.2.2. France Drug delivery devices market, by end user

6.3.2.3. UK

6.3.2.3.1. UK Drug delivery devices market, by device type
6.3.2.3.2. UK Drug delivery devices market, by end user

6.3.2.4. Italy

6.3.2.4.1. Italy Drug delivery devices market, by device type
6.3.2.4.2. Italy Drug delivery devices market, by end user

6.3.2.5. Spain

6.3.2.5.1. Spain Drug delivery devices market, by device type
6.3.2.5.2. Spain Drug delivery devices market, by end user

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe Drug delivery devices market, by device type
6.3.2.6.2. Rest of Europe Drug delivery devices market, by end user

6.3.3. Europe Drug delivery devices market, by device type
6.3.4. Europe Drug delivery devices market, by end user

6.4. Asia-Pacific

6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific Drug delivery devices market, by country

6.4.2.1. Japan

6.4.2.1.1. Japan Drug delivery devices market, by device type
6.4.2.1.2. Japan Drug delivery devices market, by end user

6.4.2.2. China

6.4.2.2.1. China Drug delivery devices market, by device type
6.4.2.2.2. China Drug delivery devices market, by end user

6.4.2.3. Australia

6.4.2.3.1. Australia Drug delivery devices market, by device type
6.4.2.3.2. Australia Drug delivery devices market, by end user

6.4.2.4. South Korea

6.4.2.4.1. South Korea Drug delivery devices market, by device type
6.4.2.4.2. South Korea Drug delivery devices market, by end user

6.4.2.5. India

6.4.2.5.1. India Drug delivery devices market, by device type
6.4.2.5.2. India Drug delivery devices market, by end user

6.4.2.6. Rest of Asia-Pacific

6.4.2.6.1. Rest of Asia-Pacific Drug delivery devices market, by device type
6.4.2.6.2. Rest of Asia-Pacific Drug delivery devices market, by end user

6.4.3. Asia-Pacific Drug delivery devices market, by device type
6.4.4. Asia-Pacific Drug delivery devices market, by end user

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. LAMEA Drug delivery devices market, by country

6.5.2.1. Brazil

6.5.2.1.1. Brazil Drug delivery devices market, by device type
6.5.2.1.2. Brazil Drug delivery devices market, by end user

6.5.2.2. South Africa

6.5.2.2.1. South Africa Drug delivery devices market, by device type
6.5.2.2.2. South Africa Drug delivery devices market, by end user

6.5.2.3. Saudi Arabia

6.5.2.3.1. Saudi Arabia Drug delivery devices market, by device type
6.5.2.3.2. Saudi Arabia Drug delivery devices market, by end user

6.5.2.4. Rest of LAMEA

6.5.2.4.1. Rest of LAMEA Drug delivery devices market, by device type
6.5.2.4.2. Rest of LAMEA Drug delivery devices market, by end user

6.5.3. LAMEA Drug delivery devices market, by device type
6.5.4. LAMEA Drug delivery devices market, by end user

CHAPTER 7: COMPANY PROFILES:

7.1. 3M Company

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance

7.2. AstraZeneca PLC

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. BECTON, DICKINSON AND COMPANY

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance

7.4. Boehringer Ingelheim group

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. Consort Medical plc

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product Portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. GlaxoSmithKline plc

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments

7.7. Insulet Corporation

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance

7.8. Medtronic Plc.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance

7.9. Sulzer Ltd. (Medmix Systems AG)

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. West Pharmaceuticals Services, Inc.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 02. SMART CAPSULE FOR DRUG DELIVERY AVAILABLE IN THE MARKET
TABLE 03. DRUG DELIVERY DEVICES MARKET FOR SMART PILLS, BY REGION 2018–2026 ($MILLION)
TABLE 04. DRUG DELIVERY DEVICES MARKET FOR DRUG ELUTING STENTS , BY REGION 2018–2026 ($MILLION)
TABLE 05. DRUG DELIVERY DEVICES MARKET FOR DRUG ELUTING STENTS, BY REGION 2018–2026 ($MILLION)
TABLE 06. DRUG DELIVERY DEVICES MARKET FOR SAFETY SYRINGES, BY REGION 2018–2026 ($MILLION)
TABLE 07. DRUG DELIVERY DEVICES MARKET FOR TRANSDERMAL PATCHES, BY REGION 2018–2026 ($MILLION)
TABLE 08. DRUG DELIVERY DEVICES MARKET FOR OTHERS DRUG DELIVERY, BY REGION 2018–2026 ($MILLION)
TABLE 09. DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 10. DRUG DELIVERY DEVICES MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION 2018–2026 ($MILLION)
TABLE 11. DRUG DELIVERY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION 2018–2026 ($MILLION)
TABLE 12. DRUG DELIVERY DEVICES MARKET FOR OTHER END USER, BY REGION 2018–2026 ($MILLION)
TABLE 13. DRUG DELIVERY DEVICES MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 15. U.S. DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 16. U.S. DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 17. CANADA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 18. CANADA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 19. MEXICO DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 20. MEXICO DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 21. NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 22. NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 23. EUROPE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 24. GERMANY DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 25. GERMANY DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 26. FRANCE DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 27. FRANCE DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 28. UK DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 29. UK DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 30. ITALY DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 31. ITALY DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 32. SPAIN DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 33. SPAIN DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 34. REST OF EUROPE DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 35. REST OF EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 36. EUROPE DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 37. EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 38. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 39. JAPAN DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 40. JAPAN DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 41. CHINA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 42. CHINA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 43. AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 44. AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 45. SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 46. SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 47. INDIA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 48. INDIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 49. REST OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 50. REST OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 51. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 52. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 53. LAMEA DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 54. BRAZIL DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 55. BRAZIL DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 56. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 57. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 58. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 59. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 60. REST OF LAMEA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 61. REST OF LAMEA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 62. LAMEA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 63. LAMEA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 64. 3M: COMPANY SNAPSHOT
TABLE 65. 3M: OPERATING SEGMENTS
TABLE 66. 3M: PRODUCT PORTFOLIO
TABLE 67. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 68. ASTRAZENECA: OPERATING SEGMENTS
TABLE 69. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 70. BECTON, DICKINSON AND COMPANY: SNAPSHOT
TABLE 71. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 72. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 73. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 74. BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 75. BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 76. CONSORT: COMPANY SNAPSHOT
TABLE 77. CONSORT: OPERATING SEGMENTS
TABLE 78. CONSORT: PRODUCT PORTFOLIO
TABLE 79. GSK: COMPANY SNAPSHOT
TABLE 80. GSK: OPERATING SEGMENTS
TABLE 81. GSK: OPERATING SEGMENTS
TABLE 82. INSULET: COMPANY SNAPSHOT
TABLE 83. INSULET: OPERATING SEGMENTS
TABLE 84. INSULET: PRODUCT PORTFOLIO
TABLE 85. MEDTRONIC: COMPANY SNAPSHOT
TABLE 86. MEDTRONIC: OPERATING SEGMENTS
TABLE 87. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 88. SULZER: COMPANY SNAPSHOT
TABLE 89. SULZER: OPERATING SEGMENTS
TABLE 90. SULZER: PRODUCT PORTFOLIO
TABLE 91. WEST PHARMA: COMPANY SNAPSHOT
TABLE 92. WEST PHARMA: OPERATING SEGMENTS
TABLE 93. WEST PHARMA: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. DRUG DELIVERY DEVICES MARKET SEGMENTATION
FIGURE 02. TOP PLAYER POSITIONING, 2018
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. LOW-MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. HIGH BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTION
FIGURE 08. HIGH INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09. IMPACT ANALYSES, DRUG DELIVERY DEVICES MARKET
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES CAMERAS FOR SMART PILLS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR DRUG ELUTING STENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR DRUG ELUTING STENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR SAFETY SYRINGES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR TRANSDERMAL PATCHES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR OTHER DRUG DELIVERY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR HOSPITALS AND DIAGNOSTIC CENTRES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR OTHER END USER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 19. 3M: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. 3M: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 21. 3M: REVENUE SHARE BY REGION, 2018(%)
FIGURE 22. ASTRAZENECA: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. ASTRAZENECA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. ASTRAZENECA: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. BECTON, DICKINSON AND COMPANY REVENUE SHARE BY REGION, 2018 (%)
FIGURE 28. BOEHRINGER INGELHEIM: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. BOEHRINGER INGELHEIM: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. BOEHRINGER INGELHEIM: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31. NET SALES, 2016–2018 ($MILLION)
FIGURE 32. CONSORT: NET SALES BY DIVISION, 2018 (%)
FIGURE 33. CONSORT: NET SALES BY REGION, 2018 (%)
FIGURE 34. GSK: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. GSK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36. GSK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37. INSULET: REVENUE, 2016–2018 ($MILLION)
FIGURE 38. INSULET: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 40. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 41. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 42. SULZER: REVENUE, 2016–2018 ($MILLION)
FIGURE 43. SULZER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 44. SULZER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 45. WEST PHARMA: REVENUE, 2016–2018 ($MILLION)
FIGURE 46. WEST PHARMA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 47. WEST PHARMA: REVENUE SHARE BY REGION, 2018 (%)

 
 

Drug delivery devices are medical tools which are designed to deliver a therapeutic agent to a specific site of administration. Furthermore, the adoption of drug delivery devices is expected to increase due to rise in the medical procedures, high demand for less painful, non-invasive, and cost-effective device type, rising demand of self-administration, and rising number of geriatric populations.

Upsurge in cases of chronic diseases and increase in prevalence of diabetes make it imperative to use various types of drug delivery system to provide therapeutic effect to the patients. Moreover, factors such as high demand of home-based healthcare and surge in affordability in the developing economies are projected to supplement the market growth. However, stringent government regulations for the approval of drug delivery devices and ignorance of the new and effective drug delivery devices are expected to impede the market growth.

The use of drug delivery devices is highest in North America, owing to increased adoption of advanced drug delivery products and heavy expenditure by the government on healthcare, followed by Europe and Asia-Pacific. In addition, drug delivery devices providers and distributors focus to expand their presence in the emerging economies, which is anticipated to drive the market growth.

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, Subscription @ $699 T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The total market value of drug delivery devices market is $19,061.4 million in 2018.

A. The forcast period for drug delivery devices market is 2019 to 2026

A. The market value of drug delivery devices market in 2019 is $19,938.9 million.

A. The base year is 2018 in drug delivery devices market

A. Top companies such as, 3M Company, Consort Medical plc, GlaxoSmithKline plc, Medtronic Plc., and Sulzer Ltd. (Medmix Systems AG) held a high market position in 2018. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Smart pills segment is the most influencing segment owing to their ability of delivering up to 1 ml of medication to a specific region of the GI tract such as the jejunum, ileum, colon and other regions.

A. The major factor that fuels the growth of the global drug delivery devices market includes growth in development of novel biologics which require the use of drug delivery devices for administration in the treatment of chronic diseases such as cancer and others.

A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 8.4%. This is attributed to the improvements in health standards, surge in disposable incomes, and advancements in technology for the development of drug delivery systems.

A. Drug delivery devices are medical devices which are employed in the delivery of a drug or therapeutic agent via a specific route of administration. Some of the type of drug delivery devices present in the market include drug eluting stents, smart pills, inhalers, nebulizers and others.

A. Drug delivery devices help to change the profile of drug release, including absorption, distribution, and elimination to improve product safety and efficacy. It also sees the patient convenience and compliance with the drug.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Drug Delivery Devices Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $0.00
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts